{"id":8181,"date":"2020-05-13T10:07:23","date_gmt":"2020-05-13T08:07:23","guid":{"rendered":"http:\/\/campusvygon.com\/es\/?p=8181"},"modified":"2025-09-29T20:49:17","modified_gmt":"2025-09-29T18:49:17","slug":"farmacos-vesicantes-a-traves-de-una-linea-media","status":"publish","type":"post","link":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/","title":{"rendered":"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media"},"content":{"rendered":"<p><strong><a href=\"http:\/\/campusvygon.com\/es\/project\/whitepaper-farmacos-irritantes-a-traves-de-una-linea-media\/\" target=\"_blank\" rel=\"noopener\">Descarga en pdf<\/a><\/strong><\/p>\n<hr \/>\n<p><span data-contrast=\"auto\">Seg\u00fan las recomendaciones, la l\u00ednea media al tener una punta ubicada a un nivel intermedio &#8211; ni perif\u00e9rico ni en VCS &#8211; permite la administraci\u00f3n de <\/span><b><span data-contrast=\"auto\">tratamientos <\/span><\/b><b><span data-contrast=\"auto\">compatible<\/span><\/b><b><span data-contrast=\"auto\">s<\/span><\/b><b><span data-contrast=\"auto\"> con la v\u00eda <\/span><\/b><b><span data-contrast=\"auto\">perif\u00e9ric<\/span><\/b><b><span data-contrast=\"auto\">a<\/span><\/b><b><span data-contrast=\"auto\">. <\/span><\/b><span data-contrast=\"auto\">Por lo tanto<\/span><span data-contrast=\"auto\">,<\/span><span data-contrast=\"auto\"> esto<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">no incluye f\u00e1rmacos hiperosmolares, irritantes ni vesicantes.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">\u00bfY si eso <\/span><span data-contrast=\"auto\">fuera<\/span><span data-contrast=\"auto\"> a cambiar?<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<h2><b><span data-contrast=\"auto\">\u00bfPara qu\u00e9 tipo de tratamientos se suele usar el midline?<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">Si miramos a las pr<\/span><span data-contrast=\"auto\">\u00e1<\/span><span data-contrast=\"auto\">cticas a nivel global <\/span><span data-contrast=\"auto\">respecto a <\/span><span data-contrast=\"auto\">este tipo de cat\u00e9ter, podemos constatar que <\/span><span data-contrast=\"auto\">en <\/span><span data-contrast=\"auto\">muchos <\/span><span data-contrast=\"auto\">casos, <\/span><span data-contrast=\"auto\">se procura usar <\/span><span data-contrast=\"auto\">el <\/span><span data-contrast=\"auto\">midline dejando su extremidad al principio de la vena axilar<\/span><span data-contrast=\"auto\">.<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Sin embargo, al ser cat\u00e9teres cuya longitud va de <\/span><b><span data-contrast=\"auto\">8<\/span><\/b> <span data-contrast=\"auto\">hasta<\/span> <b><span data-contrast=\"auto\">25<\/span><\/b><b><span data-contrast=\"auto\">cm<\/span><\/b><span data-contrast=\"auto\"> y seg\u00fan d<\/span><span data-contrast=\"auto\">\u00f3<\/span><span data-contrast=\"auto\">nde est\u00e9 <\/span><b><span data-contrast=\"auto\">el sitio de inserci\u00f3n<\/span><\/b> <span data-contrast=\"auto\">en el brazo<\/span><span data-contrast=\"auto\">, <\/span><b><span data-contrast=\"auto\">la posici\u00f3n de la punta puede variar y estar en distintos puntos del tramo <\/span><\/b><b><span data-contrast=\"auto\">axilo<\/span><\/b><b><span data-contrast=\"auto\">-subclavio<\/span><\/b><b><span data-contrast=\"auto\">. <\/span><\/b><span data-contrast=\"auto\">Por esta raz\u00f3n en Europa, la nomenclatura <\/span><span data-contrast=\"auto\">GAVeCeLT<\/span><span data-contrast=\"auto\"> distingue <\/span><a href=\"\/mini-midline-linea-media\/\"><span data-contrast=\"none\">dos<\/span><span data-contrast=\"none\"> tipos de <\/span><span data-contrast=\"none\">midlines<\/span><span data-contrast=\"none\">:<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"8\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">El<\/span> <b><span data-contrast=\"auto\">mini-midline<\/span><\/b><span data-contrast=\"auto\">: cat\u00e9ter de <\/span><b><span data-contrast=\"auto\">8-10cm<\/span><\/b><span data-contrast=\"auto\"> que se puede insertar en el antebrazo o el brazo cuya punta <\/span><span data-contrast=\"auto\">tiene una localizaci\u00f3n que <\/span><b><span data-contrast=\"auto\">no va m\u00e1s all\u00e1 <\/span><\/b><b><span data-contrast=\"auto\">d<\/span><\/b><b><span data-contrast=\"auto\">e la cavidad axilar<\/span><\/b><span data-contrast=\"auto\">;<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559737&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"8\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">El <\/span><b><span data-contrast=\"auto\">m<\/span><\/b><b><span data-contrast=\"auto\">idline<\/span><\/b><span data-contrast=\"auto\">, llamado tambi\u00e9n <\/span><b><span data-contrast=\"auto\">clavicular<\/span><\/b><span data-contrast=\"auto\">, de <\/span><b><span data-contrast=\"auto\">20-25cm<\/span><\/b> <span data-contrast=\"auto\">siempre insertado en venas profundas del brazo cuya punta se <\/span><span data-contrast=\"auto\">sit\u00faa<\/span><span data-contrast=\"auto\"> en el <\/span><b><span data-contrast=\"auto\">tramo <\/span><\/b><b><span data-contrast=\"auto\">tor\u00e1cico<\/span><\/b><b><span data-contrast=\"auto\"> de la vena axilar <\/span><\/b><span data-contrast=\"auto\">o hasta la <\/span><b><span data-contrast=\"auto\">vena subclavia<\/span><\/b><span data-contrast=\"auto\">.<\/span><\/li>\n<\/ul>\n<p><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559737&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><a href=\"http:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/corp-avec-veines-3\/\" rel=\"attachment wp-att-14370\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-14370 alignleft\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Corp-avec-veines-3.jpg\" alt=\"\" width=\"426\" height=\"527\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Corp-avec-veines-3.jpg 812w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Corp-avec-veines-3-242x300.jpg 242w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Corp-avec-veines-3-768x951.jpg 768w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Corp-avec-veines-3-271x335.jpg 271w\" sizes=\"(max-width: 426px) 100vw, 426px\" \/><\/a><\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:2,&quot;335551620&quot;:2,&quot;335559685&quot;:360,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><br \/>\n<\/span><\/p>\n<p><span data-contrast=\"auto\">Tambi\u00e9n tenemos que considerar que si un cat\u00e9ter <\/span><span data-contrast=\"auto\">midline<\/span><span data-contrast=\"auto\"> de 20cm o 25cm se ins<\/span><span data-contrast=\"auto\">erta en una parte <\/span><b><span data-contrast=\"auto\">m\u00e1s distal <\/span><\/b><span data-contrast=\"auto\">del <\/span><b><span data-contrast=\"auto\">brazo <\/span><\/b><span data-contrast=\"auto\">(cerca de la flexura) o incluso en el <\/span><b><span data-contrast=\"auto\">antebrazo<\/span><\/b><span data-contrast=\"auto\">, su punta puede ubicarse en <\/span><span data-contrast=\"auto\">el <\/span><b><span data-contrast=\"auto\">tramo inicial de la vena axilar<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:360,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">El <\/span><b><span data-contrast=\"auto\">objetivo del <\/span><\/b><b><span data-contrast=\"auto\">midline<\/span><\/b> <span data-contrast=\"auto\">es poder ser una primera opci\u00f3n en la <\/span><span data-contrast=\"auto\">terapia intravascular<\/span><b><span data-contrast=\"auto\"> perif\u00e9rica de media\/larga duraci\u00f3n<\/span><\/b><span data-contrast=\"auto\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:360,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\">-Por encima de 6 d\u00edas<\/span><\/b><span data-contrast=\"auto\">, <\/span><b><span data-contrast=\"auto\">sustituyen a los cat\u00e9teres cortos perif\u00e9ricos<\/span><\/b><span data-contrast=\"auto\"> que no pueden dar las prestaciones requeridas<\/span><span data-contrast=\"auto\">: <\/span><span data-contrast=\"auto\">obligan a los profesionales a la canalizaci\u00f3n de varios dispositivos para poder cubrir la duraci\u00f3n del tratamiento, provocando el agotamiento del capital venoso del paciente<\/span><span data-contrast=\"auto\">;<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><br \/>\n<\/span><\/p>\n<p><span data-contrast=\"auto\">-Por otra parte, permite <\/span><b><span data-contrast=\"auto\">racionalizar el uso del PICC <\/span><\/b><span data-contrast=\"auto\">que consiste en:<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><br \/>\n<\/span><\/p>\n<ul>\n<li><span data-contrast=\"auto\"><strong>Pasar f\u00e1rmacos<\/strong> de media\/larga duraci\u00f3n para tratamientos <\/span><b><span data-contrast=\"auto\">compatib<\/span><\/b><b><span data-contrast=\"auto\">les con la perfusi\u00f3n <\/span><\/b><b><span data-contrast=\"auto\">perif\u00e9rica<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:1134,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><br \/>\n<\/span><i><span data-contrast=\"auto\">E<\/span><\/i><i><span data-contrast=\"auto\">n este caso, la l\u00ednea media axilar es m\u00e1s adecuada que el PICC para los tratamientos de hasta <\/span><\/i><b><i><span data-contrast=\"auto\">30 d\u00edas<\/span><\/i><\/b><i><span data-contrast=\"auto\"> (media duraci\u00f3n), en su versi\u00f3n <\/span><\/i><b><i><span data-contrast=\"auto\">PUR<\/span><\/i><\/b> <i><span data-contrast=\"auto\">clase IIa<\/span><\/i><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:1134,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\"><strong>Pasar f\u00e1rmacos<\/strong> <\/span><b><span data-contrast=\"auto\">hiperosmolares<\/span><\/b><span data-contrast=\"auto\"> y\/o de <\/span><b><span data-contrast=\"auto\">pH&lt;5 o &gt;9<\/span><\/b><b><span data-contrast=\"auto\">, o vesicantes<\/span><\/b><span data-contrast=\"auto\"> para un tratamiento de media\/larga duraci\u00f3n.<\/span><\/li>\n<\/ul>\n<p>Hasta hace bien poco, esta regla era estricta, sin embargo en Espa\u00f1a y en EEUU hay experiencia del uso del midline axilar o clavicular para ciertos f\u00e1rmacos que pertenecen a la categor\u00eda \u201cadministraci\u00f3n por v\u00eda central\u201d.<\/p>\n<h2><b><span data-contrast=\"auto\">\u00bfQu\u00e9 dicen las recomendaciones?<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">En el programa espa\u00f1ol <\/span><b><span data-contrast=\"auto\">Flebitis 0<\/span><\/b><span data-contrast=\"auto\">, se advierte <\/span><span data-contrast=\"auto\">de <\/span><span data-contrast=\"auto\">los <\/span><b><span data-contrast=\"auto\">riesgos <\/span><\/b><span data-contrast=\"auto\">de la perfusi\u00f3n de f\u00e1rmacos <\/span><b><span data-contrast=\"auto\">agresivos <\/span><\/b><span data-contrast=\"auto\">para el sistema vascular <\/span><b><span data-contrast=\"auto\">perif\u00e9rico<\/span><\/b><span data-contrast=\"auto\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<blockquote><p>El pH de la sangre var\u00eda del 7,35-7,45. Osmolaridad de la sangre 340 mOsm\/l. <strong>La flebitis qu\u00edmica se produce por la irritaci\u00f3n de la vena por soluciones \u00e1cidas, alcalinas e hipert\u00f3nicas<\/strong>. Cuanto m\u00e1s \u00e1cida (con valores inferiores a 7,0 y especialmente inferiores a 4,1) o alcalina (con valores de pH por encima de 7,0, especialmente por encima de 9,0) sea una soluci\u00f3n, m\u00e1s irritante ser\u00e1 (Kokotis, 1998). La osmolaridad tambi\u00e9n influir\u00e1 en la irritaci\u00f3n de la vena.<\/p><\/blockquote>\n<p style=\"text-align: center\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14371 aligncenter\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/tabla-f0.jpg\" alt=\"\" width=\"635\" height=\"546\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/tabla-f0.jpg 635w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/tabla-f0-300x258.jpg 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/tabla-f0-335x288.jpg 335w\" sizes=\"(max-width: 635px) 100vw, 635px\" \/>Alto riesgo (AR) &gt; 500 mOsm\/l, Riesgo moderado (RM) entre 350 y 500 mOsm\/l y Bajo riesgo (BR) &lt; 350 mOsm\/l. <span data-contrast=\"auto\">NPT: no administrar &gt; 600 mOsm\/l.<\/span> (Carballo et al. 2004)<\/p>\n<p><span data-contrast=\"auto\">Adem\u00e1s seg\u00fan otras fuentes tambi\u00e9n debe<\/span><span data-contrast=\"auto\">r\u00edan incluirse en la lista:\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Ampicilina s\u00f3dica pH 8,0-10,0.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Ciprofloxacino pH 3,3-3,9.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Ganciclovir pH 9,0-11,0.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Gentamicina 3,0-5,5.\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Levofloxacino pH 4-3- 5-3 285-325 mOsm\/l.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Ofloxacino.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Penicilina pH 7,5.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Rifampicina pH 7,8-8,8.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Trimetropin-sulfametoxazol pH 9,5-11,0. <\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Las gu\u00edas<\/span><span data-contrast=\"auto\"> americanas <\/span><b><span data-contrast=\"auto\">Infusion<\/span><\/b> <b><span data-contrast=\"auto\">Therapy<\/span><\/b> <b><span data-contrast=\"auto\">Standards<\/span><\/b> <b><span data-contrast=\"auto\">of<\/span><\/b> <b><span data-contrast=\"auto\">Practice<\/span><\/b><b><span data-contrast=\"auto\"> de la<\/span><\/b><b><span data-contrast=\"auto\"> INS <\/span><\/b><span data-contrast=\"auto\">(<\/span><span data-contrast=\"auto\">Infusion<\/span><span data-contrast=\"auto\"> Nurse<\/span><span data-contrast=\"auto\">s<\/span> <span data-contrast=\"auto\">Society<\/span><span data-contrast=\"auto\">) de 2016<\/span><span data-contrast=\"auto\">, en el apartado <\/span><span data-contrast=\"auto\">sobre <\/span><span data-contrast=\"auto\">midlines<\/span><span data-contrast=\"auto\">, recomiendan lo siguiente<\/span><span data-contrast=\"auto\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<ol>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"4\" data-aria-posinset=\"1\" data-aria-level=\"1\">\n<blockquote><p><em>Considere las caracter\u00edsticas de la infusi\u00f3n (figura 1) en conjunto con la duraci\u00f3n prevista del tratamiento (por ejemplo, 1-4 semanas).\u00a0\u00a0<\/em><\/p><\/blockquote>\n<\/li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"4\" data-aria-posinset=\"2\" data-aria-level=\"1\">\n<blockquote><p><em>Considere un cat\u00e9ter de l\u00ednea media para los medicamentos y soluciones como antimicrobianos, reemplazo de fluidos, y analg\u00e9sicos con caracter\u00edsticas que son bien tolerado por las venas perif\u00e9ricas.\u00a0\u00a0<\/em><\/p><\/blockquote>\n<\/li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"4\" data-aria-posinset=\"2\" data-aria-level=\"1\">\n<blockquote><p><em>No use cat\u00e9teres de l\u00ednea media para terapia vesicante continua, nutrici\u00f3n parenteral o infusiones con una osmolaridad superior a 900 mOsm\/L.\u00a0<\/em><\/p><\/blockquote>\n<\/li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"4\" data-aria-posinset=\"2\" data-aria-level=\"1\">\n<blockquote><p><em>Tenga cuidado con la administraci\u00f3n intermitente de vesicantes debido al riesgo de extravasaci\u00f3n no detectada. La administraci\u00f3n de vancomicina por menos de 6 d\u00edas a trav\u00e9s de un cat\u00e9ter de l\u00ednea media se encontr\u00f3 que estar seguro en un estudio.\u00a0<\/em><\/p><\/blockquote>\n<\/li>\n<\/ol>\n<p><span data-contrast=\"auto\"><a href=\"http:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/recomendaciones-ins-jpg-corregida\/\" rel=\"attachment wp-att-25567\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-25567 aligncenter\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Recomendaciones-INS.jpg-corregida.jpg\" alt=\"\" width=\"757\" height=\"454\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Recomendaciones-INS.jpg-corregida.jpg 1000w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Recomendaciones-INS.jpg-corregida-300x180.jpg 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Recomendaciones-INS.jpg-corregida-768x461.jpg 768w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Recomendaciones-INS.jpg-corregida-335x201.jpg 335w\" sizes=\"(max-width: 757px) 100vw, 757px\" \/><\/a><\/span><\/p>\n<p><span data-contrast=\"auto\">El manual <\/span><span data-contrast=\"auto\">GAVeCeLT<\/span><span data-contrast=\"auto\"> sobre PICC y <\/span><span data-contrast=\"auto\">Midline<\/span> <span data-contrast=\"auto\">indica <\/span><span data-contrast=\"auto\">que<\/span><b><span data-contrast=\"auto\"> la infusi\u00f3n perif\u00e9rica <\/span><\/b><span data-contrast=\"auto\">debe hacerse<\/span><b><span data-contrast=\"auto\"> \u00fanicamente con f\u00e1rmacos o soluciones cuyo pH est\u00e9 entre 5 y 9<\/span><\/b><b><span data-contrast=\"auto\">,<\/span><\/b><b><span data-contrast=\"auto\"> cuya osmolaridad est\u00e9 por debajo de 750mOsm\/L<\/span><\/b> <b><span data-contrast=\"auto\">y q<\/span><\/b><b><span data-contrast=\"auto\">ue no sea vesicante <\/span><\/b><span data-contrast=\"auto\">incluyendo como excepci\u00f3n, las<\/span><span data-contrast=\"auto\"> nutriciones parenterales de corta duraci\u00f3n &lt;800mOsm\/L.<\/span> <span data-contrast=\"auto\">Tambi\u00e9n se\u00f1ala que<\/span><b><span data-contrast=\"auto\"> la l\u00ednea media que sea axilar o subclavia <\/span><\/b><span data-contrast=\"auto\">es considerado<\/span><span data-contrast=\"auto\"> acceso venoso<\/span><b><span data-contrast=\"auto\"> perif\u00e9rico.<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<h2><b><span data-contrast=\"auto\">\u00bf<\/span><\/b><b><span data-contrast=\"auto\">E<\/span><\/b><b><span data-contrast=\"auto\">xisten otras aplicaciones<\/span><\/b><b><span data-contrast=\"auto\"> farmacol\u00f3gicas con <\/span><\/b><b><span data-contrast=\"auto\">la l\u00ednea media?<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">Ante todo, hay que tener en cuenta un dato de importancia: la <\/span><b><span data-contrast=\"auto\">diferencia de flujo<\/span><\/b><span data-contrast=\"auto\"> que existe<\/span> <span data-contrast=\"auto\">en un <\/span><span data-contrast=\"auto\">recorrido venoso est\u00e1ndar<\/span><span data-contrast=\"auto\"> entre la <\/span><span data-contrast=\"auto\">vena bas\u00edlica, la <\/span><span data-contrast=\"auto\">vena axilar y la vena subclavia.<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-8207\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Clasificaci\u00f3n-vena-flujo-300x225.jpg\" alt=\"Clasificacion vena\/flujo\" width=\"628\" height=\"471\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Clasificaci\u00f3n-vena-flujo-300x225.jpg 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Clasificaci\u00f3n-vena-flujo-335x251.jpg 335w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Clasificaci\u00f3n-vena-flujo.jpg 567w\" sizes=\"(max-width: 628px) 100vw, 628px\" \/><\/span><\/p>\n<p><span data-contrast=\"auto\">Efectivamente existen otras aplicaciones farmacol\u00f3gicas; aunque el recorrido cient\u00edfico y cl\u00ednico es todav\u00eda corto, existen datos que nos ense\u00f1an que es posible.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">El estudio observacional Caparas (2017) sobre 1086 pacientes, demuestra excelentes resultados con el uso de un <\/span><b><span data-contrast=\"auto\">midline<\/span><\/b> <b><span data-contrast=\"auto\">axilar<\/span><\/b><span data-contrast=\"auto\"> para la administraci\u00f3n de <\/span><b><span data-contrast=\"auto\">Vancomicina<\/span><\/b><span data-contrast=\"auto\">:<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"> <img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-8188\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Complicaciones-300x225.jpg\" alt=\"Complicaciones relacionadas con el cateterismo\" width=\"470\" height=\"352\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Complicaciones-300x225.jpg 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Complicaciones-335x251.jpg 335w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Complicaciones.jpg 567w\" sizes=\"(max-width: 470px) 100vw, 470px\" \/><\/span><\/p>\n<p><span data-contrast=\"none\">En su estudio <\/span><i><span data-contrast=\"none\">U<\/span><\/i><i><span data-contrast=\"none\">so de cat\u00e9teres venosos de l\u00ednea media en pacientes <\/span><\/i><i><span data-contrast=\"none\">h<\/span><\/i><i><span data-contrast=\"none\">ospitalizados<\/span><\/i><span data-contrast=\"none\">, el ETI del hospital Virgen de la Victoria de M\u00e1laga public\u00f3 resultados muy interesante<\/span><span data-contrast=\"none\">s<\/span><span data-contrast=\"none\"> sobre el <\/span><span data-contrast=\"none\">midline<\/span> <b><span data-contrast=\"none\">axilar<\/span><\/b><span data-contrast=\"none\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Sobre un total de 1016 pacientes, <\/span><i><span data-contrast=\"none\">el 40 % de los cat\u00e9teres se canaliz\u00f3 por mal acceso venoso del paciente (406), el 42% por tratamiento intravenoso largo (427) y <\/span><\/i><b><i><span data-contrast=\"none\">el 18% por tratamiento irritante (183).<\/span><\/i><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><i><span data-contrast=\"auto\">Los tratamientos <\/span><\/i><b><i><span data-contrast=\"auto\">irritantes<\/span><\/i><\/b><i><span data-contrast=\"auto\"> administrados en mayor porcentaje fueron: <\/span><\/i><b><i><span data-contrast=\"auto\">Isoplasmal<\/span><\/i><\/b><b><i><span data-contrast=\"auto\"> 30.6% (56), Cloruro pot\u00e1sico 19.1% (35), Vancomicina 12% (22), Cloxacilina 9.3% (17)<\/span><\/i><\/b><i><span data-contrast=\"auto\">.<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><i><span data-contrast=\"auto\">Los pacientes que precisaron <\/span><\/i><b><i><span data-contrast=\"auto\">cambiar el CM<\/span><\/i><\/b><b><i><span data-contrast=\"auto\"> (Cat\u00e9ter <\/span><\/i><\/b><b><i><span data-contrast=\"auto\">Midline<\/span><\/i><\/b><b><i><span data-contrast=\"auto\">)<\/span><\/i><\/b><b><i><span data-contrast=\"auto\"> por un cat\u00e9ter venoso central<\/span><\/i><\/b><i><span data-contrast=\"auto\"> representaban el 2.2% en el grupo de mal acceso venoso (9), el 4.2 % en el de tratamiento largo (18) y el <\/span><\/i><b><i><span data-contrast=\"auto\">7.1% en el de tratamiento irritante (13)<\/span><\/i><\/b><i><span data-contrast=\"auto\">.\u00a0<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-8200 alignleft\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Causas-de-la-retirada-300x231.png\" alt=\"Causa de retirada del cat\u00e9ter\" width=\"456\" height=\"351\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Causas-de-la-retirada-300x231.png 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Causas-de-la-retirada-335x257.png 335w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Causas-de-la-retirada.png 596w\" sizes=\"(max-width: 456px) 100vw, 456px\" \/><\/p>\n<p><span data-contrast=\"none\">No se encontr\u00f3<\/span><b><i><span data-contrast=\"none\"> diferencia<\/span><\/i><\/b><i><span data-contrast=\"none\"> en cuanto a las <\/span><\/i><b><i><span data-contrast=\"none\">complicaciones<\/span><\/i><\/b><i><span data-contrast=\"none\"> entre pacientes a los que se <\/span><\/i><i><span data-contrast=\"auto\">les administr\u00f3 <\/span><\/i><b><i><span data-contrast=\"auto\">tratamiento antibi\u00f3tico con bajo riesgo de flebitis<\/span><\/i><\/b><i><span data-contrast=\"auto\"> y aquellos en los que el <\/span><\/i><b><i><span data-contrast=\"auto\">tratamiento era irritante<\/span><\/i><\/b><i><span data-contrast=\"auto\">.\u00a0<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Durante su ponencia en el congreso <\/span><span data-contrast=\"auto\">Grumav<\/span><span data-contrast=\"auto\"> del 2017, el ETI del <\/span><span data-contrast=\"auto\">hospital OSI Araba de Vitoria<\/span><span data-contrast=\"auto\">,<\/span> <span data-contrast=\"auto\">usuario de la l\u00ednea media <\/span><b><span data-contrast=\"auto\">clavicular<\/span><\/b><span data-contrast=\"auto\">, ense\u00f1o los resultados de 4 a\u00f1os de experiencia a trav\u00e9s de un estudio observacional sobre 1841 pacientes.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Respecto a los tratamientos infundidos, <\/span><b><span data-contrast=\"auto\">45,6% fueron sustancias irritantes<\/span><\/b><span data-contrast=\"auto\">:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"> <img loading=\"lazy\" decoding=\"async\" class=\" wp-image-8201 alignright\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Sustancias-irritantes-300x231.png\" alt=\"Sustancias irritantes\" width=\"406\" height=\"313\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Sustancias-irritantes-300x231.png 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Sustancias-irritantes-335x257.png 335w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Sustancias-irritantes.png 596w\" sizes=\"(max-width: 406px) 100vw, 406px\" \/><\/span><\/p>\n<p><span data-contrast=\"auto\">Sobre el total de pacientes, el <\/span><b><span data-contrast=\"auto\">3,5% tuvo un cambio a v\u00eda central<\/span><\/b><span data-contrast=\"auto\"> y el <\/span><b><span data-contrast=\"auto\">85,6% termin\u00f3 su tratamiento <\/span><\/b><span data-contrast=\"auto\">(10,9% de exitus).<\/span> <b><span data-contrast=\"auto\">No hubo casos de flebitis<\/span><\/b><b><span data-contrast=\"auto\">,<\/span><\/b><b><span data-contrast=\"auto\"> ni de infiltraci\u00f3n<\/span><\/b><span data-contrast=\"auto\">;<\/span> <span data-contrast=\"auto\">la trombosis fue de 0,4\/1000 d\u00edas de cat\u00e9teres y la <\/span><span data-contrast=\"auto\">bacteriemia<\/span><span data-contrast=\"auto\"> de 0,14\/1000 d\u00edas de cat\u00e9ter.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Est\u00e1 claro que m\u00e1s investigaci\u00f3n se necesita para aportar m\u00e1s datos sobre e<\/span><span data-contrast=\"auto\">l midline<\/span><span data-contrast=\"auto\"> y su validez en cuanto a la perfusi\u00f3n de f\u00e1rmacos irritantes. Sin embargo, estos distintos estudios abren un camino en el cual se pueden ver beneficiados muchos pacientes, siempre <\/span><span data-contrast=\"auto\">evaluando<\/span><span data-contrast=\"auto\"> los riesgos previamente a la toma de decisi\u00f3n.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-8199\" src=\"http:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-300x300.jpg\" alt=\"F\u00e1rmacos vesicantes. Puntos a tener en cuenta \" width=\"548\" height=\"548\" srcset=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-300x300.jpg 300w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-1024x1024.jpg 1024w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-150x150.jpg 150w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-768x768.jpg 768w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-70x70.jpg 70w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-335x335.jpg 335w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2-360x360.jpg 360w, https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2020\/05\/Vesicantes-qu\u00e9-tener-en-cuenta.V2.jpg 1134w\" sizes=\"(max-width: 548px) 100vw, 548px\" \/><\/p>\n<p>[accordion title=&#8217;Bibliograf\u00eda&#8217;]<span data-contrast=\"auto\">Vancomycin Administration Through a<\/span> <span data-contrast=\"auto\">Novel Midline Catheter: Summary of a<\/span> <span data-contrast=\"auto\">5-Year, 1086-Patient Experience in an<\/span> <span data-contrast=\"auto\">Urban Community Hospital<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">Jona V. Caparas, MSN, RN, CRNI, VA-BC<\/span> <span data-contrast=\"auto\">Hwei-San Hung, RNC, VA-BC<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">New York Presbyterian Queens, Flushing, NY\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">Journal of the Association of Vascular Access 2017 vol.22 n\u00ba1<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Safe administration of vancomycin<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">through a novel midline catheter: a randomized, prospective<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">clinical trial.<\/span> <span data-contrast=\"auto\">Caparas JV, Hu JP.<\/span><span data-contrast=\"auto\">\u00a0 J Vasc Access. <\/span><span data-contrast=\"auto\">2014;15(4):251-256.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Cohen E, Dadashev A, Drucker M, Samra Z,<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">Rubinstein E, et al. <\/span> <span data-contrast=\"auto\">Once-daily versus twice daily intravenous<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">administration of vancomycin for infections in<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">hospitalized patients. J Antimicrob Chemother.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">2002;49:155-160.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">their tendency to cause infusion phlebitis: a prospective<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">observational study. Scand J Infect Dis. 2002;34:512-519.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Mowry JL, Hartman LS. Intravascular thrombophlebitis<\/span> <span data-contrast=\"auto\">related to the peripheral infusion of amiodarone and<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span> <span data-contrast=\"auto\">vancomycin. West J Nurs. 2011;33(3):457-471.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Roszell S, Jones C. Intravenous administration issues. <\/span><span data-contrast=\"auto\">J Infus Nurs. 2010;33(2):112-118.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Outpatient Parenteral Antimicrobial Therapy Today Joseph A. Paladino1,2 and Donald Poretz3 1 Clinical Outcomes Research, CPL Associates, Amherst, and 2 Pharmacy, State University of New York at Buffalo, Buffalo, New York; <\/span><\/p>\n<p><span data-contrast=\"auto\">3 Infectious Diseases Physicians, Annandale, Virginia<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">Clinical Infectious Disease 2010:51 (Suppl 2)<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Uso de cat\u00e9teres venosos de l\u00ednea media en pacientes <\/span><span data-contrast=\"none\">h<\/span><span data-contrast=\"none\">ospitalizados\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">N<\/span><span data-contrast=\"auto\">.<\/span><span data-contrast=\"auto\"> Fortes<\/span><span data-contrast=\"auto\">, <\/span><span data-contrast=\"auto\">JM Fern\u00e1ndez<\/span><span data-contrast=\"auto\">, <\/span><span data-contrast=\"auto\">C<\/span><span data-contrast=\"auto\">.<\/span><span data-contrast=\"auto\"> Cruzado<\/span><span data-contrast=\"auto\">, <\/span><span data-contrast=\"auto\">S<\/span><span data-contrast=\"auto\">.<\/span><span data-contrast=\"auto\"> Garc\u00eda <\/span><span data-contrast=\"auto\">&#8211; <\/span><span data-contrast=\"auto\">Hospital Virgen de la Victoria, M\u00e1laga<\/span> <span data-contrast=\"auto\">Enfermer\u00eda global n\u00ba56 octubre 2019<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">L\u00ednea media clavicular, opci\u00f3n de acceso venoso seguro: cuatro a\u00f1os de experiencia<\/span> <span data-contrast=\"auto\">Armenteros Hospital OSI Araba de Vitoria<\/span> <span data-contrast=\"auto\">Ponencia Congreso GruMAV 2017<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Programa Flebitis 0 <\/span> <span data-contrast=\"auto\">Manual <\/span><span data-contrast=\"auto\">GAVeCeLT<\/span><span data-contrast=\"auto\"> sobre PICC y <\/span><span data-contrast=\"auto\">Midline<\/span><span data-contrast=\"auto\"> 2017<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Infusion Therapy Standards of Practice<\/span><span data-contrast=\"auto\"> \u2013 INS 2016<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span>[\/accordion]<\/p>\n<p>[authors users=\u00bb<strong>fcarrillo<\/strong>,<strong>Ravila,mpineau<\/strong>\u00ab]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Descarga en pdf Seg\u00fan las recomendaciones, la l\u00ednea media al tener una punta ubicada a un nivel intermedio &#8211; ni perif\u00e9rico ni en VCS &#8211; permite la administraci\u00f3n de tratamientos compatibles con la v\u00eda perif\u00e9rica. Por lo tanto, esto\u00a0no incluye f\u00e1rmacos hiperosmolares, irritantes ni vesicantes.\u00a0\u00a0 \u00bfY si eso fuera a cambiar?\u00a0 \u00bfPara qu\u00e9 tipo de [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":48139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[116],"tags":[318,308,303,149,315,143,316,317,319,320,310],"class_list":["post-8181","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-terapias-intravasculares","tag-farmacos-agresivos","tag-farmacos-hiperosmolares","tag-farmacos-incompatibles","tag-flebitis","tag-framacos-vesicantes","tag-linea-media","tag-midlines","tag-mini-midlines","tag-osmolaridad-extrema","tag-tratamiento-irritante","tag-vancomicina"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media - Campus Vygon Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media - Campus Vygon Espa\u00f1a\" \/>\n<meta property=\"og:description\" content=\"Descarga en pdf Seg\u00fan las recomendaciones, la l\u00ednea media al tener una punta ubicada a un nivel intermedio &#8211; ni perif\u00e9rico ni en VCS &#8211; permite la administraci\u00f3n de tratamientos compatibles con la v\u00eda perif\u00e9rica. Por lo tanto, esto\u00a0no incluye f\u00e1rmacos hiperosmolares, irritantes ni vesicantes.\u00a0\u00a0 \u00bfY si eso fuera a cambiar?\u00a0 \u00bfPara qu\u00e9 tipo de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\" \/>\n<meta property=\"og:site_name\" content=\"Campus Vygon Espa\u00f1a\" \/>\n<meta property=\"article:author\" content=\"Array\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-13T08:07:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-29T18:49:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1531\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Campus Vygon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/vygon_es\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Campus Vygon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\"},\"author\":{\"name\":\"Campus Vygon\",\"@id\":\"https:\/\/campusvygon.com\/es\/#\/schema\/person\/75f06ca9d47ad2da0ff801057b0588fe\"},\"headline\":\"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media\",\"datePublished\":\"2020-05-13T08:07:23+00:00\",\"dateModified\":\"2025-09-29T18:49:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\"},\"wordCount\":1567,\"commentCount\":13,\"image\":{\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg\",\"keywords\":[\"f\u00e1rmacos agresivos\",\"f\u00e1rmacos hiperosmolares\",\"f\u00e1rmacos incompatibles\",\"flebitis\",\"framacos vesicantes\",\"linea media\",\"midlines\",\"mini-midlines\",\"osmolaridad extrema\",\"tratamiento irritante\",\"vancomicina\"],\"articleSection\":[\"Terapias Intravasculares\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\",\"url\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\",\"name\":\"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media - Campus Vygon Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/campusvygon.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg\",\"datePublished\":\"2020-05-13T08:07:23+00:00\",\"dateModified\":\"2025-09-29T18:49:17+00:00\",\"author\":{\"@id\":\"https:\/\/campusvygon.com\/es\/#\/schema\/person\/75f06ca9d47ad2da0ff801057b0588fe\"},\"breadcrumb\":{\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage\",\"url\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg\",\"contentUrl\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg\",\"width\":2560,\"height\":1531},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/campusvygon.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/campusvygon.com\/es\/#website\",\"url\":\"https:\/\/campusvygon.com\/es\/\",\"name\":\"Campus Vygon Espa\u00f1a\",\"description\":\"Un espacio para aprender sobre procedimientos y t\u00e9cnicas sanitarias de la mano de profesionales de referencia.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/campusvygon.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/campusvygon.com\/es\/#\/schema\/person\/75f06ca9d47ad2da0ff801057b0588fe\",\"name\":\"Campus Vygon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2016\/02\/cropped-Vygon-Value-Life-150x150.jpg\",\"url\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2016\/02\/cropped-Vygon-Value-Life-150x150.jpg\",\"contentUrl\":\"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2016\/02\/cropped-Vygon-Value-Life-150x150.jpg\",\"caption\":\"Campus Vygon\"},\"description\":\"A place to learn about\u00a0health procedures\u00a0and techniques from\u00a0leading professionals.\",\"sameAs\":[\"https:\/\/www.vygon.es\/\",\"Array\",\"https:\/\/www.instagram.com\/vygonespana\/\",\"https:\/\/www.linkedin.com\/company\/vygon-espaa\",\"https:\/\/x.com\/https:\/\/twitter.com\/vygon_es\",\"https:\/\/www.youtube.com\/user\/VygonSpain\"],\"url\":\"https:\/\/campusvygon.com\/es\/author\/vygon\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media - Campus Vygon Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/","og_locale":"es_ES","og_type":"article","og_title":"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media - Campus Vygon Espa\u00f1a","og_description":"Descarga en pdf Seg\u00fan las recomendaciones, la l\u00ednea media al tener una punta ubicada a un nivel intermedio &#8211; ni perif\u00e9rico ni en VCS &#8211; permite la administraci\u00f3n de tratamientos compatibles con la v\u00eda perif\u00e9rica. Por lo tanto, esto\u00a0no incluye f\u00e1rmacos hiperosmolares, irritantes ni vesicantes.\u00a0\u00a0 \u00bfY si eso fuera a cambiar?\u00a0 \u00bfPara qu\u00e9 tipo de [&hellip;]","og_url":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/","og_site_name":"Campus Vygon Espa\u00f1a","article_author":"Array","article_published_time":"2020-05-13T08:07:23+00:00","article_modified_time":"2025-09-29T18:49:17+00:00","og_image":[{"width":2560,"height":1531,"url":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg","type":"image\/jpeg"}],"author":"Campus Vygon","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/vygon_es","twitter_misc":{"Escrito por":"Campus Vygon","Tiempo de lectura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#article","isPartOf":{"@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/"},"author":{"name":"Campus Vygon","@id":"https:\/\/campusvygon.com\/es\/#\/schema\/person\/75f06ca9d47ad2da0ff801057b0588fe"},"headline":"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media","datePublished":"2020-05-13T08:07:23+00:00","dateModified":"2025-09-29T18:49:17+00:00","mainEntityOfPage":{"@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/"},"wordCount":1567,"commentCount":13,"image":{"@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage"},"thumbnailUrl":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg","keywords":["f\u00e1rmacos agresivos","f\u00e1rmacos hiperosmolares","f\u00e1rmacos incompatibles","flebitis","framacos vesicantes","linea media","midlines","mini-midlines","osmolaridad extrema","tratamiento irritante","vancomicina"],"articleSection":["Terapias Intravasculares"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/","url":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/","name":"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media - Campus Vygon Espa\u00f1a","isPartOf":{"@id":"https:\/\/campusvygon.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage"},"image":{"@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage"},"thumbnailUrl":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg","datePublished":"2020-05-13T08:07:23+00:00","dateModified":"2025-09-29T18:49:17+00:00","author":{"@id":"https:\/\/campusvygon.com\/es\/#\/schema\/person\/75f06ca9d47ad2da0ff801057b0588fe"},"breadcrumb":{"@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#primaryimage","url":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg","contentUrl":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2025\/09\/Portada-Farmacos-irritantes-scaled.jpeg","width":2560,"height":1531},{"@type":"BreadcrumbList","@id":"https:\/\/campusvygon.com\/es\/farmacos-vesicantes-a-traves-de-una-linea-media\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/campusvygon.com\/es\/"},{"@type":"ListItem","position":2,"name":"F\u00e1rmacos irritantes a trav\u00e9s de una l\u00ednea media"}]},{"@type":"WebSite","@id":"https:\/\/campusvygon.com\/es\/#website","url":"https:\/\/campusvygon.com\/es\/","name":"Campus Vygon Espa\u00f1a","description":"Un espacio para aprender sobre procedimientos y t\u00e9cnicas sanitarias de la mano de profesionales de referencia.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/campusvygon.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/campusvygon.com\/es\/#\/schema\/person\/75f06ca9d47ad2da0ff801057b0588fe","name":"Campus Vygon","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2016\/02\/cropped-Vygon-Value-Life-150x150.jpg","url":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2016\/02\/cropped-Vygon-Value-Life-150x150.jpg","contentUrl":"https:\/\/campusvygon.com\/es\/wp-content\/uploads\/sites\/7\/2016\/02\/cropped-Vygon-Value-Life-150x150.jpg","caption":"Campus Vygon"},"description":"A place to learn about\u00a0health procedures\u00a0and techniques from\u00a0leading professionals.","sameAs":["https:\/\/www.vygon.es\/","Array","https:\/\/www.instagram.com\/vygonespana\/","https:\/\/www.linkedin.com\/company\/vygon-espaa","https:\/\/x.com\/https:\/\/twitter.com\/vygon_es","https:\/\/www.youtube.com\/user\/VygonSpain"],"url":"https:\/\/campusvygon.com\/es\/author\/vygon\/"}]}},"_links":{"self":[{"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/posts\/8181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/comments?post=8181"}],"version-history":[{"count":43,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/posts\/8181\/revisions"}],"predecessor-version":[{"id":48141,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/posts\/8181\/revisions\/48141"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/media\/48139"}],"wp:attachment":[{"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/media?parent=8181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/categories?post=8181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/campusvygon.com\/es\/wp-json\/wp\/v2\/tags?post=8181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}